Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maricel C Gozo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancers|October 14, 2022
FOXC2 Promotes Vasculogenic Mimicry in Ovarian CancerMaria Sol Recouvreux, Jiangyong Miao, Maricel C Gozo, et al.
Oncotarget|September 17, 2016
FOXC2 augments tumor propagation and metastasis in osteosarcomaMaricel C Gozo, Dongyu Jia, Paul-Joseph Aspuria, et al.
The Journal of Clinical Investigation|September 17, 2019
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcomeMarwan Fakih, Ching Ouyang, Chongkai Wang, et al.
Experimental Cell Research|May 8, 2020
HOXB13 controls cell state through super-enhancersPaul-Joseph Aspuria, Dong-Joo Cheon, Maricel C Gozo, et al.
The Oncologist|December 21, 2019
A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver MetastasesChongkai Wang, John Park, Ching Ouyang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancers|October 14, 2022
FOXC2 Promotes Vasculogenic Mimicry in Ovarian CancerMaria Sol Recouvreux, Jiangyong Miao, Maricel C Gozo, et al.
Oncotarget|September 17, 2016
FOXC2 augments tumor propagation and metastasis in osteosarcomaMaricel C Gozo, Dongyu Jia, Paul-Joseph Aspuria, et al.
The Journal of Clinical Investigation|September 17, 2019
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcomeMarwan Fakih, Ching Ouyang, Chongkai Wang, et al.
Experimental Cell Research|May 8, 2020
HOXB13 controls cell state through super-enhancersPaul-Joseph Aspuria, Dong-Joo Cheon, Maricel C Gozo, et al.
The Oncologist|December 21, 2019
A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver MetastasesChongkai Wang, John Park, Ching Ouyang, et al.
Pageof 1